Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04421573 · ClinicalTrials.gov registry record · NA
Cervical Plexus Hydrodissection With D5W for PTSD
A NA study of PTSD, sponsored by Dr. Dean Reeves Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 4
- Study locations
NCT04421573: Recruiting NA study of PTSD, sponsored by Dr. Dean Reeves Clinic.
NCT04421573 is a NA study of PTSD that is actively recruiting participants, run by Dr. Dean Reeves Clinic. The registered enrollment target is 24 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04421573, a NA study of PTSD, is actively recruiting participants, sponsored by Dr. Dean Reeves Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 4
- Study locations
Study Summary
PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with a delayed/usual treatment control.
Primary Outcome
Percentage consent rate for qualifying participants
Conditions Studied
Interventions
- PROCEDURE BCPHD with D5W
- PROCEDURE Waiting period with usual care
Study Locations (4)
Oregon
- Paul W. Johnson, D.O., Clinic. - Portland
- NW Regen - Tigard
Kentucky
- Danesh Mazloomdoost - Lexington
Wisconsin
- Eric Phillippi M.D. Clinic - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-07-10 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT04421573 shows while recruiting
NCT04421573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (92% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which BCPHD with D5W is the first listed.
NCT04421573 reports a single indexed study location in Oregon, Kentucky, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04421573 about?
NCT04421573 is a clinical study titled "Cervical Plexus Hydrodissection With D5W for PTSD". PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PT...
What is the current status of trial NCT04421573?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-07-10. Estimated completion is 2027-10-01.
What conditions does trial NCT04421573 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT04421573?
The interventions under investigation include: BCPHD with D5W (PROCEDURE), Waiting period with usual care (PROCEDURE).
Who is sponsoring clinical trial NCT04421573?
This trial is sponsored by Dr. Dean Reeves Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04421573 being conducted?
This trial has 4 study locations across Kentucky, Oregon, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04421573's enrollment target sits among peer trials
24 136th of 154 higher than 18 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI